Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The Brain as a Drug Target -

The Brain as a Drug Target

Shafiqur Rahman (Herausgeber)

Buch | Hardcover
468 Seiten
2011
Academic Press Inc (Verlag)
978-0-12-385506-0 (ISBN)
CHF 218,20 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
The brain is protected by the blood-brain barrier and this barrier prevents many drugs from entering the brain. This title discusses various drug delivery and targeting strategies that are being developed to enhance the transport and distribution of drugs into the brain. It discusses discoveries, approaches, and ideas.

Shafiqur Rahman, Ph.D. is Professor of Pharmacology in the Department of Pharmaceutical Sciences at South Dakota State University (SDSU) in Brookings, USA. He received his Ph.D. in Neuropharmacology from the Memorial University of Newfoundland, Canada. Dr. Rahman completed his post-doctoral fellowship in the Department of Psychiatry from Indiana University School of Medicine in Indianapolis in USA. Prior to joining SDSU, he worked as research scientist and faculty at the University of Kentucky in Lexington, USA and the University of Toronto, Canada. Dr. Rahman's research focus is drug discovery in neuropharmacology, i.e. the development of novel therapeutic candidates for the treatment of drug addiction and neuropsychiatric disorders. His research and scholarship has resulted in over 125 publications and 11 edited books/book chapters. Dr. Rahman served as editor, editorial board member and reviewer for numerous Scientific Journals and review panels related to drug addiction, neuropharmacology, and drug discovery research. Dr. Rahman is also a member of several professional societies or organizations, including Society for Neuroscience, American Society for Experimental Neurotherapeutics, and American Society for Pharmacology and Experimental Therapeutics.

1. Monoamine Transporters: Vulnerable and Vital Doorkeepers
Zhicheng Lin, Juan J. Canales, Thröstur Björgvinsson, Morgane M. Thomsen, Hong Qu, Qing-Rong Liu, Gonzalo E. Torres, and S. Barak Caine
2. Therapeutic Targets in Alzheimer Disease and Related Tauopathies
Christopher P. Corbo and Alejandra del C. Alonso
3. Therapeutic Targets for Neuroprotection and/or Enhancement of Functional Recovery Following Traumatic Brain Injury
Matthew L. Kelso and James R. Pauly
4. Insulin, Synaptic Function, and Opportunities for Neuroprotection
John G. Mielke and Yu-Tian Wang
5. Molecular Alterations in Glioblastoma: Potential Targets for Immunotherapy
Azizul Haque, Naren L. Banik, and Swapan K. Ray
6. Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor System
Patrick J. Ronan, and Cliff H. Summers
7. Molecular targets of alcohol action: translational research for pharmacotherapy development and screening
Giorgio Gorini, Richard L. Bell, and R. Dayne Mayfield
8. Brain Nicotinic Receptors as Emerging Targets for Drug Addiction: Neurobiology to Translational Research
Shafiqur Rahman
9. Glutamatergic Neuroplasticity in Cocaine Addiction
Joachim D. Uys and Kathryn J. Reissner
10. Role of the serotonergic system in alcohol dependence: from animal models to clinics
Verity R. Johnson, Jason M. Weedman, Youssef Sari

Erscheint lt. Verlag 22.2.2011
Reihe/Serie Progress in Molecular Biology and Translational Science
Verlagsort San Diego
Sprache englisch
Maße 152 x 229 mm
Gewicht 800 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Neurologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 0-12-385506-3 / 0123855063
ISBN-13 978-0-12-385506-0 / 9780123855060
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Aus Klinik & Praxis

von Christian Henke; Johannes Rieger; Rebecca Seiler

Buch | Softcover (2025)
Urban & Fischer in Elsevier (Verlag)
CHF 54,60